RACHEL ROSOL: Open Payments
NPI 1801661699 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 38 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $811 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $455 |
| Eisai Inc. | 3 | $158 |
| JAZZ PHARMACEUTICALS INC. | 1 | $134 |
| Baxter Healthcare | 1 | $47 |
| Neurelis, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| W. L. Gore & Associates, Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
Products named: QULIPTA, UBRELVY, Leqembi, EPIDIOLEX, FLOSEAL, VALTOCO, GORE TAG Thoracic Branch Endoprosthesis, Symbravo.
Industry payments across FL — which companies pay providers there.
